Benchmark Transitions
-
Services:
- Smoking permitted in designated area
- Housing services
- Outpatient mental health facility
- Clients with co-occurring mental and substance use disorders
- Young adults
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Mental health treatment
- Substance use treatment
- Young Adults
- Private for-profit organization
- TB screening
- Laboratory testing
- Court-ordered outpatient treatment
- Family psychoeducation
- Supported housing
- Supported employment
- Lurasidone
- Paliperidone
- Cariprazine
- Clozapine
- Antipsychotics used in treatment of SMI
- Fluphenazine
- Aripiprazole
- Ziprasidone
- Risperidone
- Haloperidol
- Olanzapine
- Quetiapine
- Vaping permitted in designated area
- Private health insurance
- Cash or self-payment
- Telemedicine/telehealth therapy
- Eye Movement Desensitization and Reprocessing therapy
- Integrated Mental and Substance Use Disorder treatment
- Individual psychotherapy
- Group therapy
- Cognitive behavioral therapy
- Dialectical behavior therapy
- Activity therapy
- Partial hospitalization/day treatment
- Outpatient
Facility Smoking Policy
Recovery Support Services
Facility Type
Special Programs/Groups Offered
Type of Care
Age Groups Accepted
Facility Operation (e.g., Private, Public)
Testing
Ancillary Services
Pharmacotherapies
Facility Vaping Policy
Payment/Insurance/Funding Accepted
Treatment Approaches
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)